About Keythera Pharma
Keythera Pharma is a company based in Suzhou (China) founded in 2020. It operates as a HealthTech. Keythera Pharma has raised $15.35 million across 2 funding rounds from investors including Yijing Capital. Keythera Pharma offers products and services including KF-0210, KBP-2506, and KBP-2205.
- Headquarter Suzhou, China
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Keythera (Suzhou) Biopharmaceutical Co., Ltd.
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$15.35 M (USD)
in 2 rounds
-
Latest Funding Round
$15.35 M (USD), Series A
Mar 21, 2021
- Investors
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Keythera Pharma
Keythera Pharma offers a comprehensive portfolio of products and services, including KF-0210, KBP-2506, and KBP-2205. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Innovative drug developed for oncology and autoimmune diseases.
Drug candidate targeting unmet clinical needs in diseases.
Innovative drug in clinical trials for critical conditions.
Funding Insights of Keythera Pharma
Keythera Pharma has successfully raised a total of $15.35M across 2 strategic funding rounds. The most recent funding activity was a Series A round of $15.35 million completed in March 2021. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 2
- Last Round Series A — $15.4M
- First Round First Round
- Investors Count 1
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Mar, 2021 | Amount | Series A - Keythera Pharma | Valuation | Yijing Capital |
|
| Jun, 2020 | Amount | Series A - Keythera Pharma | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Keythera Pharma
Keythera Pharma has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include Yijing Capital. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture capital firm focused on multiple sectors
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Keythera Pharma
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Keythera Pharma
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Keythera Pharma Comparisons
Competitors of Keythera Pharma
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Frequently Asked Questions about Keythera Pharma
When was Keythera Pharma founded?
Keythera Pharma was founded in 2020.
Where is Keythera Pharma located?
Keythera Pharma is headquartered in Suzhou, China. It is registered at Suzhou, Jiangsu, China.
Is Keythera Pharma a funded company?
Keythera Pharma is a funded company, having raised a total of $15.35M across 2 funding rounds to date.
What does Keythera Pharma do?
Keythera Pharma, based in Suzhou, China, is focused on the development of innovative small-molecule drugs targeting major unmet clinical needs in oncology and autoimmune diseases. A proprietary Affinity Detection by Mass Spectroscopy (ADMS) platform is utilized to screen up to 250,000 compounds daily, integrating bioinformatics, cheminformatics, and AI to accelerate drug discovery. Multiple drug pipelines are maintained, including candidates in Phase I and II clinical trials. The company is supported by a highly qualified team with international expertise in drug development.
What products or services does Keythera Pharma offer?
Keythera Pharma offers KF-0210, KBP-2506, and KBP-2205.
Who are Keythera Pharma's investors?
Keythera Pharma has 1 investor. Key investors include Yijing Capital.